Short answer
ACME UNITED CORP (ACU) filed an 8-K current report with the SEC on July 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 fiscal 2026 results released for quarter ended June 30, 2026.
ACME UNITED CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 fiscal 2026 results released for quarter ended June 30, 2026
- Financial details and management commentary contained in Exhibit 99.1 press release
Item EX-99.1 · Exhibit EX-99.1
- Q2 sales rose 16% to $62.7M, with 8% comparable growth excluding My Medic, indicating broad-based underlying demand
- Net income increased 6% to $5.1M and diluted EPS 5% to $1.22, despite tariff-related margin pressure
- Gross margin expanded to 42.6% from 41.0%, helped by My Medic’s direct-to-consumer business and improving product demand
- Six-month net income fell 6% to $6.0M and diluted EPS 7% to $1.46, reflecting weak first-quarter performance
- Net debt increased to $27.3M after $14.5M My Medic spending, while a new $65M facility extends financing through July 15, 2029
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACME UNITED CORP 8-K filings
Get the next ACU 8-K as it lands
Follow ACU for push alerts, or ask the research agent what this filing means.